The Potential Therapeutic Prospect of PANoptosis in Heart Failure

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Nov 25

PMID 39583864

Authors

Yunfeng Jia

Yayi Liu

Yiming Zuo

Junping Zhang

Yanyang Li

Xuezheng Liu

Shichao Lv

Affiliations

Soon will be listed here.

Abstract

Heart failure (HF) represents a serious manifestation or advanced stage of various cardiac diseases. HF continues to impose a significant global disease burden, characterized by high rates of hospitalization and fatality. Furthermore, the pathogenesis and pathophysiological processes underlying HF remain incompletely understood, complicating its prevention and treatment strategies. One significant pathophysiological mechanism associated with HF is the systemic inflammatory response. PANoptosis, a novel mode of inflammatory cell death, has been extensively studied in the context of infectious diseases, neurodegenerative disorders, cancers, and other inflammatory conditions. Recent investigations have revealed that PANoptosis-related genes are markedly dysregulated in HF specimens. Consequently, the PANoptosis-mediated inflammatory response may represent a potential mechanism and therapeutic target for HF. This paper conducts a comprehensive analysis of the molecular pathways that drive PANoptosis. We discuss its role and potential therapeutic targets in HF, thereby providing valuable insights for clinical treatment and the development of novel therapies.

References

Kovacs S, Miao E . Gasdermins: Effectors of Pyroptosis. Trends Cell Biol. 2017; 27(9):673-684. PMC: 5565696. DOI: 10.1016/j.tcb.2017.05.005. View

Qin J, Yang Q, Wang Y, Shi M, Zhao X, Zhou Y . The role of pyroptosis in heart failure and related traditional chinese medicine treatments. Front Pharmacol. 2024; 15:1377359. PMC: 11168204. DOI: 10.3389/fphar.2024.1377359. View

Wang J, Deng B, Liu Q, Huang Y, Chen W, Li J . Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis. 2020; 11(7):574. PMC: 7382480. DOI: 10.1038/s41419-020-02777-3. View

Conos S, Chen K, De Nardo D, Hara H, Whitehead L, Nunez G . Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci U S A. 2017; 114(6):E961-E969. PMC: 5307433. DOI: 10.1073/pnas.1613305114. View

Banoth B, Tuladhar S, Karki R, Sharma B, Briard B, Kesavardhana S . ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem. 2020; 295(52):18276-18283. PMC: 7939383. DOI: 10.1074/jbc.RA120.015924. View

Guo J, Luo Y, Zuo J, Teng J, Shen B, Liu X . Echinacea Polyphenols Inhibit NLRP3-Dependent Pyroptosis, Apoptosis, and Necroptosis via Suppressing NO Production during Lipopolysaccharide-Induced Acute Lung Injury. J Agric Food Chem. 2023; 71(19):7289-7298. DOI: 10.1021/acs.jafc.2c08382. View

Gao X, Liu C, Zhang Y, Wang Y, Zhou L, Li X . The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death Differ. 2021; 29(3):527-539. PMC: 8901615. DOI: 10.1038/s41418-021-00872-2. View

Guo S, Liu Y, Gao L, Xiao F, Shen J, Xing S . TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway. Int J Biol Sci. 2020; 16(8):1335-1348. PMC: 7085222. DOI: 10.7150/ijbs.41130. View

Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I . Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol. 2004; 43(2):295-301. DOI: 10.1016/j.jacc.2003.09.026. View

10.

Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M . RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res. 2014; 103(2):206-16. DOI: 10.1093/cvr/cvu146. View

11.

Chen H, Xie X, Xiao H, Liang W, Lin Z, Lin B . A Pilot Study About the Role of PANoptosis-Based Genes in Atherosclerosis Development. J Inflamm Res. 2023; 16:6283-6299. PMC: 10750489. DOI: 10.2147/JIR.S442260. View

12.

Yu X, Ruan Y, Huang X, Dou L, Lan M, Cui J . Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochem Biophys Res Commun. 2019; 523(1):140-146. DOI: 10.1016/j.bbrc.2019.12.027. View

13.

Zhang Z, Yang Z, Wang S, Feng S, Wang X, Mao J . Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats: The mediating role of phosphatidylinositol-3-kinase/protein kinase B/tumor protein 53 signaling pathway. J Ethnopharmacol. 2024; 330:118264. DOI: 10.1016/j.jep.2024.118264. View

14.

Ma Z, Xie K, Xue X, Li J, Yang Y, Wu J . Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA. J Ethnopharmacol. 2024; 328:118057. DOI: 10.1016/j.jep.2024.118057. View

15.

Singla D, Johnson T, Tavakoli Dargani Z . Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy. Cells. 2019; 8(10). PMC: 6830113. DOI: 10.3390/cells8101224. View

16.

Audia J, Yang X, Crockett E, Housley N, Haq E, ODonnell K . Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol. 2018; 113(5):32. PMC: 6396295. DOI: 10.1007/s00395-018-0692-z. View

17.

Fauconnier J, Meli A, Thireau J, Roberge S, Shan J, Sassi Y . Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proc Natl Acad Sci U S A. 2011; 108(32):13258-63. PMC: 3156220. DOI: 10.1073/pnas.1100286108. View

18.

Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim H . NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell. 2023; 186(13):2783-2801.e20. PMC: 10330523. DOI: 10.1016/j.cell.2023.05.005. View

19.

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18):e895-e1032. DOI: 10.1161/CIR.0000000000001063. View

20.

Xu X, Lai Y, Hua Z . Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2018; 39(1). PMC: 6340950. DOI: 10.1042/BSR20180992. View